Argose

Argose, Inc. was a medical technology company dedicated to the development of non-invasive glucose monitoring systems for patients with diabetes. The company's core technology utilized a proprietary blue-light auto-fluorescence method to detect spectral signals from the skin that correlated with blood glucose levels, aiming to eliminate the need for painful finger-stick tests. Based in Rockville, Maryland, and Waltham, Massachusetts, Argose conducted clinical research to validate its system's accuracy in both Type 1 and Type 2 diabetes populations. Despite its innovative approach to non-invasive diagnostics and a strong team of spectroscopy experts, the company ceased operations in the mid-2000s without successfully bringing a commercial product to market.